| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 660.937 | 702.748 | 966.092 | 653.720 | 755.464 | 1.361.025 | 1.231.293 | 769.562 |
| Total Income - EUR | - | - | 661.306 | 719.238 | 979.796 | 654.938 | 760.176 | 1.363.961 | 1.232.760 | 770.570 |
| Total Expenses - EUR | - | - | 514.389 | 634.104 | 834.813 | 642.181 | 628.714 | 1.043.307 | 983.367 | 616.263 |
| Gross Profit/Loss - EUR | - | - | 146.917 | 85.135 | 144.983 | 12.756 | 131.463 | 320.654 | 249.392 | 154.307 |
| Net Profit/Loss - EUR | - | - | 140.051 | 77.956 | 135.192 | 6.215 | 124.019 | 293.222 | 213.948 | 130.336 |
| Employees | - | - | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Empermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 155 | 71.416 | 90.858 | 56.240 | 26.425 | 15.449 | 8.564 | 32.266 |
| Current Assets | - | - | 447.331 | 596.169 | 649.487 | 560.702 | 592.395 | 755.603 | 955.656 | 600.650 |
| Inventories | - | - | 19.708 | 28.038 | 49.317 | 25.546 | 22.883 | 41.086 | 22.494 | 22.454 |
| Receivables | - | - | 363.256 | 498.771 | 500.365 | 433.821 | 497.642 | 714.177 | 929.447 | 577.532 |
| Cash | - | - | 64.367 | 69.360 | 99.805 | 101.336 | 71.870 | 341 | 3.714 | 664 |
| Shareholders Funds | - | - | 140.095 | 215.482 | 294.286 | 226.782 | 292.023 | 391.697 | 459.867 | 418.415 |
| Social Capital | - | - | 44 | 45 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | 307.391 | 452.802 | 446.634 | 390.613 | 324.888 | 381.965 | 510.095 | 221.160 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 2.334 | 1.906 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Empermed Srl